Back to search

Ireland· IE-PA-PA1410/012/001

Urografin 30 % w/v Solution for infusion

A diatrizoic acid product containing sodium amidotrizoate + meglumine amidotrizoate + sodium hydroxide, registered in Ireland by Bayer Limited. The same ATC class is registered in 9 of our 19 countries.

ATC V08AA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedUrografin 30 % w/v Solution for infus…ATCV08AA01REGISTER NO.IE-PA-PA1410/012/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Diatrizoic acid is registered in 9 of 19 countries.

Countries holding a registration under ATC V08AA01 (diatrizoic acid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 5 of them publish a price we can compare per daily dose

Diatrizoic acid · ATC V08AA01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Sodium amidotrizoate + Meglumine amidotrizoate + Sodium hydroxide
Manufacturer
Bayer Limited
Country
Ireland (IE)
ATC code
V08AA01
ATC class
Diatrizoic acid
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1410/012/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/40670210-50c8-4371-8058-8225928464d7
GET /v1/drugs/40670210-50c8-4371-8058-8225928464d7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": null,
  "source": "hpra",
  "atc_all": [
    "V08AA01"
  ],
  "strength": null,
  "pa_number": "PA1410/012/001",
  "substances": [
    "Sodium amidotrizoate",
    "Meglumine amidotrizoate",
    "Sodium hydroxide"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1988",
  "dispensing_status": "Product subject to Restricted Prescription (C)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about diatrizoic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.